Pharmaceutical Technology

JUNE 6, 2023

According to Globaldata, it is involved in 5 clinical trials, which are ongoing. The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. Pharma Mar Overview Pharma Mar discovers, develops and markets marine-derived drugs to treat cancer.

Hormones 100

Hormones In-Vitro Genotype Bacteria 100

Drug Discovery World

SEPTEMBER 28, 2023

This is likely in part because their byproduct, lactic acid, is known to inhibit pathogenic bacteria 25. And, in the endometrium, a decrease in Lactobacillus may affect embryo attachment and promote the growth of detrimental bacteria. This article will focus on one such area of great unmet need and promise: women’s health.

Clinical Trials 65

Clinical Trials Clinical Trials Regulation Bacteria 65

pharmaphorum

JUNE 9, 2022

Matt Regan, the company’s CEO, explains how Micreos Pharmaceuticals’ technology and its fast evolving Drug Discovery and Drug Development capabilities can help bring novel therapies to market. Not to mention that traditional antibiotics are designed to attack a broad spectrum of bacteria within the host’s body.

Bacteria 104

Bacteria Development In-Vitro Drugs 104

The Pharma Data

APRIL 28, 2021

Fosmanogepix is currently in Phase 2 clinical trials evaluating the safety and efficacy of both intravenous (IV) and oral formulations for the treatment of patients with life-threatening invasive fungal infections caused by molds, yeasts and rare molds (e.g., NEW YORK–(BUSINESS WIRE)– Pfizer Inc. and Scedosporium spp).

Containment 40

Containment Clinical Trials Clinical Trials In-Vitro 40

The Pharma Data

OCTOBER 22, 2020

The Company intends to use the net proceeds from this offering to support its planned New Drug Application submission for oral sulopenem for the treatment of uncomplicated urinary tract infections in patients with quinolone-resistant pathogens, the continued clinical development of sulopenem, and for working capital and general corporate purposes.

In-Vitro 40

In-Vitro Clinical Trials Clinical Trials Sales 40

Drug Discovery World

FEBRUARY 15, 2023

The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. Over 250 clinical trials are currently in progress, and novel immuno-oncological treatments are already proving to be successful. This continues to be the standard of care.

Research 52

Research In-Vitro In-Vivo Development 52